✦ LIBER ✦

New targets for an old drug

✍ Scribed by Jacek J. Slon-Usakiewicz; Andrew Pasternak; Neil Reid; Leticia M. Toledo-Sherman

Book ID: 111636983
Publisher: BioMed Central
Year: 2004
Tongue: English
Weight: 184 KB
Volume: 1
Category: Article
ISSN: 1542-6416
DOI: 10.1385/cp:1:3-4:227

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

✍ Leticia M. Toledo-Sherman; Leroi Desouza; Christopher M. Hosfield; Linda Liao; K 📂 Article 📅 2004 🏛 BioMed Central 🌐 English ⚖ 633 KB

The cyclooxygenase-2 stucture: new drugs

The cyclooxygenase-2 stucture: new drugs for an old target?

✍ Garavito, R. Michael 📂 Article 📅 1996 🏛 Nature Publishing Group 🌐 English ⚖ 700 KB

New roles for an old enzyme: Na,K-ATPase

New roles for an old enzyme: Na,K-ATPase emerges as an interesting drug target

✍ A. Aperia 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 641 KB

Targeting cell signaling pathways for dr

Targeting cell signaling pathways for drug discovery: An old lock needs a new key

✍ Bharat B. Aggarwal; Gautam Sethi; Veera Baladandayuthapani; Sunil Krishnan; Shis 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 274 KB

## Abstract In this age of targeted therapy, the failure of most current drug‐discovery efforts to yield safe, effective, and inexpensive drugs has generated widespread concern. Successful drug development has been stymied by a general focus on target selection rather than clinical safety and effic

Ivermectin is a potent inhibitor of flav

Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug

✍ Mastrangelo, E.; Pezzullo, M.; De Burghgraeve, T.; Kaptein, S.; Pastorino, B.; D 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 647 KB

Informatics: New targets for old drugs

✍ Crunkhorn, Sarah 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 156 KB